General Hematology
Systematic Review | Stem cell transplantation for systemic sclerosis.
1 Aug, 2022 | 12:10h | UTCStem cell transplantation for systemic sclerosis – Cochrane Library
Summary: Stem cell transplantation for the treatment of systemic sclerosis – Cochrane Library
Systematic Review | Antiplatelet agents for the treatment of deep venous thrombosis.
26 Jul, 2022 | 12:44h | UTCAntiplatelet agents for the treatment of deep venous thrombosis – Cochrane Library
Summary: Aspirin and similar drugs for the treatment of deep vein thrombosis (DVT) – Cochrane Library
RCT | Ticagrelor is ineffective for reducing vaso-occlusive crises in pediatric sickle cell disease.
25 Jul, 2022 | 12:50h | UTC
EASL Clinical Practice Guidelines on hemochromatosis.
18 Jul, 2022 | 11:47h | UTCEASL Clinical Practice Guidelines on haemochromatosis – Journal of Hepatology
M-A | Oral iron supplementation in patients with heart failure.
13 Jul, 2022 | 11:17h | UTC
ESAIC/ESRA guideline | Regional anesthesia in patients on antithrombotic drugs.
11 Jul, 2022 | 12:46h | UTC
Commentary on Twitter
Just saw this from 2/22-More reasonable recommendations than ASRA for timeframe to stop Xa's before regional anesthesia (not 96hrs) but including drug levels in some recs
Regional anaesthesia in pts on antithrombotic drugs: Joint ESAIC/ESRA guidelines https://t.co/PrF72HFWzG— Steven Cohn, MD (@preopconsult) July 10, 2022
RCT | Neutralizing COVID-19 convalescent plasma does not benefit adults hospitalized with COVID-19.
8 Jul, 2022 | 11:59h | UTC
Review | Sickle cell disease.
7 Jul, 2022 | 12:59h | UTCSickle Cell Disease: A Review – JAMA (free for a limited period)
Audio Clinical Review: Sickle Cell Disease – JAMA
Coagulation and transfusion updates from 2021.
7 Jul, 2022 | 12:36h | UTCCoagulation and Transfusion Updates from 2021 – Journal of Cardiothoracic and Vascular Anesthesia
M-A | DOACs vs. VKAs in atrial fibrillation patients with bioprosthetic heart valve.
7 Jul, 2022 | 12:15h | UTC
M-A | Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital.
5 Jul, 2022 | 12:19h | UTCEM Cases | The 7 Ts of massive hemorrhage protocols.
5 Jul, 2022 | 11:35h | UTCEM Cases: The 7 Ts of Massive Hemorrhage Protocols – emDocs
2022 Guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.
1 Jul, 2022 | 11:50h | UTCRelated:
Two new studies show no benefit of Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19.
1 Jul, 2022 | 11:49h | UTCCommentaries:
Antithrombotic Prophylaxis No Help in Outpatients With COVID — Two trials show no differences between patients who received enoxaparin vs standard of care – MedPage Today (free registration required)
Commentary on Twitter (thread – click for more)
Early in the pandemic we wondered whether antithrombotic therapy in outpatients with #COVID19 would prevent #thrombosis ❓
Several trials were started globally and the ACTIV-4B trial was previously reported⬇️ https://t.co/Q15WcZwDIA
Now, we publish the OVID and ETHIC trials?
— The Lancet Haematology (@TheLancetHaem) June 30, 2022
RCT: Prothrombin complex concentrate vs. plasma for post–cardiopulmonary bypass coagulopathy and bleeding.
30 Jun, 2022 | 10:50h | UTCProthrombin Complex Concentrate vs Plasma for Post–Cardiopulmonary Bypass Coagulopathy and Bleeding: A Randomized Clinical Trial – JAMA Surgery (free for a limited period)
Commentary on Twitter
In this RCT of cardiac surgical patients, there was no significant difference in postoperative bleeding among patients receiving prothrombin complex concentrates (PCCs) or plasma. Fewer patients with PCCs required intraoperative RBCs after treatment. https://t.co/vqtNX7hQxA
— JAMA Surgery (@JAMASurgery) June 29, 2022
Consensus Paper: Diagnosis and treat-to-target management of macrophage activation syndrome in children.
24 Jun, 2022 | 11:13h | UTC
M-A: Intravenous iron vs. oral iron vs. no iron with or without erythropoiesis‐ stimulating agents for cancer patients with anemia.
23 Jun, 2022 | 10:10h | UTC
Analysis of thromboembolic and thrombocytopenic events after the AstraZeneca, Pfizer, and Moderna COVID-19 vaccines in 3 Nordic countries.
15 Jun, 2022 | 11:17h | UTC
Cohort Study: Mortality among patients undergoing blood transfusion in relation to donor sex and parity.
14 Jun, 2022 | 10:56h | UTCNews Release: Red blood cell units from female blood donors do not increase risk of death of transfused patients – Karolinska Institutet
BSH guideline for the hematological management of major hemorrhage.
13 Jun, 2022 | 10:53h | UTC
Systematic Review: Evidence-based perioperative diagnosis and management of pulmonary embolism.
9 Jun, 2022 | 10:34h | UTC
Brief Review: Management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery.
6 Jun, 2022 | 10:55h | UTC
BSH Guidelines for thrombophilia testing.
2 Jun, 2022 | 11:28h | UTCGuidelines for thrombophilia testing: A British Society for Haematology guideline
NIH Updated Guideline: Antithrombotic therapy in patients with COVID-19.
2 Jun, 2022 | 11:25h | UTCAntithrombotic Therapy in Patients With COVID-19 – National Institutes of Health
BIOIRON Society recommends new classification of hemochromatosis.
24 May, 2022 | 08:09h | UTCNews Release: BIOIRON Society Recommends New Classification of Hemochromatosis – ASH Clinical News
See Guidance: Hemochromatosis classification: update and recommendations by the BIOIRON Society – Blood